FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
Subcutaneous injection cuts the amount of the protein antithrombin, leading to an increase in thrombin
More Than 3.8 Million U.S. Lung Cancer Deaths Averted During 1970 to 2022
Number of averted lung cancer deaths accounted for 51.4 percent of the estimated declines in overall cancer deaths
Similar Efficacy Seen for Isodose, Dose-Escalated MHFRT, CFRT in Prostate Cancer
Physician-scored and patient-reported bowel toxicity higher with dose-escalated moderately hypofractionated radiotherapy
Common Photosensitizing Drugs Increase Skin Cancer Risk
Estrogen treatment increased the risk for all investigated skin cancers
Lung Cancer Screening Rates Increased After 2021 Update to USPSTF Guidelines
Lower odds of screening seen in association with lack of health insurance, being rural resident, not having a clinician
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placebo
Many Women Undergo Annual Mammography, Despite Biennial Screening Recommendations
75.2 percent of those reporting mammography screening in past two years reported screening in the past year
Sensorized T-Shirt Enables Early Discharge After Oncological Urology Surgery
90 percent of patients satisfied with remote patient monitoring
Longer PSA Monitoring in Patients With Persistent PSA May Reduce Overtreatment
Authors say PSA level should be assessed for at least three months after radical prostatectomy for prostate cancer to accurately document persistent PSA
Pelabresib Plus Ruxolitinib Improves Underlying Myelofibrosis
In a recent study, significantly more patients receiving the combination therapy met primary end point of reduction in spleen volume of ≥35 percent from baseline
